Skip to main content
OpenTrials

Clinical trial condition

Cholangiocarcinoma

Explore clinical trials studying Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.

491 public trials 153 recruiting studies
Refine in advanced search Browse all conditions

Cholangiocarcinoma trial results

Completed

Recurrence After Whipple's (RAW) Study

NCT04596865

Conditions
Adenocarcinoma, Ampullary Cancer, Bile Duct Cancer, +35 more
Locations
  • Monash Medical Centre Clayton, Victoria, Australia
  • Medical University Innsbruck, Anichstr. 35 A Innsbruck, Austria
  • Azienda Ospedaliero - Universitaria Di Sassari Sassari, Sardinia, Italy
  • Azienda Ospedaliero - Universitaria Policlinico Umberto I Rome, Italy
View all 29 locations
View Trial Details
Completed

A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation

NCT03684811

Conditions
Adenocarcinoma, Astrocytoma, Bile Duct Diseases, +25 more
Locations
  • Banner MD Anderson Gilbert, Arizona, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • University of Miami, Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Northwestern University, Lurie Comprehensive Cancer Center Chicago, Illinois, United States
View all 26 locations
View Trial Details
Completed

M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)

NCT03833661

Conditions
Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +19 more
Locations
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • UCSF Mount Zion Medical Ctr San Francisco, California, United States
  • Mayo Clinic in Florida - Department of Neurology Jacksonville, Florida, United States
  • H. Lee Moffitt Cancer Center and Research Institute, Inc Tampa, Florida, United States
View all 33 locations
View Trial Details
Completed

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

NCT03602079

Conditions
Adenocarcinoma, Adnexal Diseases, Bile Duct Cancer, +129 more
Locations
  • Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
  • Beth Israel Deaconess Medical Center Cancer Center Boston, Massachusetts, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Clinical Research Alliance, Inc. Lake Success, New York, United States
View Trial Details
Completed

TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers

NCT03829436

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +58 more
Locations
  • University of California - San Francisco San Francisco, California, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
View Trial Details

Related conditions